Akebia Therapeutics, Inc. (AKBA)
0.865
-0.01
(-0.69%)
USD |
NASDAQ |
Oct 02, 16:00
0.85
-0.02
(-1.73%)
After-Hours: 20:00
Akebia Therapeutics Market Cap : 235.06M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 235.06M |
| October 01, 2026 | 236.69M |
| September 30, 2026 | 250.00M |
| September 29, 2026 | 240.79M |
| September 28, 2026 | 242.69M |
| September 25, 2026 | 243.54M |
| September 24, 2026 | 249.73M |
| September 23, 2026 | 253.43M |
| September 22, 2026 | 266.31M |
| September 21, 2026 | 255.03M |
| September 18, 2026 | 248.83M |
| September 17, 2026 | 243.35M |
| September 16, 2026 | 249.41M |
| September 15, 2026 | 245.38M |
| September 14, 2026 | 261.66M |
| September 11, 2026 | 258.62M |
| September 10, 2026 | 257.20M |
| September 09, 2026 | 259.22M |
| September 08, 2026 | 279.90M |
| September 04, 2026 | 264.87M |
| September 03, 2026 | 267.20M |
| September 02, 2026 | 266.39M |
| September 01, 2026 | 256.72M |
| August 31, 2026 | 249.68M |
| August 28, 2026 | 238.75M |
| Date | Value |
|---|---|
| August 27, 2026 | 255.38M |
| August 26, 2026 | 246.33M |
| August 25, 2026 | 260.44M |
| August 24, 2026 | 244.73M |
| August 21, 2026 | 246.36M |
| August 20, 2026 | 249.84M |
| August 19, 2026 | 240.60M |
| August 18, 2026 | 231.47M |
| August 17, 2026 | 233.70M |
| August 14, 2026 | 237.18M |
| August 13, 2026 | 236.31M |
| August 12, 2026 | 242.72M |
| August 11, 2026 | 235.46M |
| August 10, 2026 | 229.35M |
| August 07, 2026 | 247.26M |
| August 06, 2026 | 259.35M |
| August 05, 2026 | 350.55M |
| August 04, 2026 | 358.70M |
| August 03, 2026 | 355.98M |
| July 31, 2026 | 353.63M |
| July 30, 2026 | 361.66M |
| July 29, 2026 | 337.55M |
| July 28, 2026 | 340.23M |
| July 27, 2026 | 342.91M |
| July 24, 2026 | 326.84M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Emergent BioSolutions, Inc. | 324.73M |
| Exelixis, Inc. | 14.53B |
| ADMA Biologics, Inc. | 2.190B |
| Arcutis Biotherapeutics, Inc. | 3.160B |
| Relay Therapeutics, Inc. | 4.143B |
Market Cap Related Metrics
| PS Ratio | 1.063 |
| Price to Book Value | 9.395 |
| Price to Free Cash Flow | 5.781 |
| Price | 0.865 |
| Earnings Yield | -12.83% |